The Indian government has invited bids for the strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL), in which it holds a 98.11% stake. The remaining 1.89% is held by Kumaon Mandal Vikas Nigam Ltd (KMVNL). The government plans to disinvest its entire stake in IMPCL through strategic disinvestment with a transfer of management control. IMPCL is a profit-making organization that manufactures ayurvedic and unani medicines and supplies them to all states under the National Ayush Mission.
Will RBI announce steep rate hikes? Nomura sees up to 50 bps increase by Dec, dismisses 125 bps hike fears
Nomura expects the RBI to pursue a limited tightening cycle, with a possible 50 bps rate hike by December, as food and energy pressures rise
September 28, 2026